nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Colitis—Docetaxel—pancreatic cancer	0.00458	0.00458	CcSEcCtD
Cefoxitin—Flushing—Tamoxifen—pancreatic cancer	0.00455	0.00455	CcSEcCtD
Cefoxitin—Candida infection—Docetaxel—pancreatic cancer	0.00455	0.00455	CcSEcCtD
Cefoxitin—Bone marrow depression—Doxorubicin—pancreatic cancer	0.00441	0.00441	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00439	0.00439	CcSEcCtD
Cefoxitin—Erythema—Tamoxifen—pancreatic cancer	0.00427	0.00427	CcSEcCtD
Cefoxitin—Erythema—Erlotinib—pancreatic cancer	0.00423	0.00423	CcSEcCtD
Cefoxitin—Haemoglobin—Sunitinib—pancreatic cancer	0.00422	0.00422	CcSEcCtD
Cefoxitin—Haemorrhage—Sunitinib—pancreatic cancer	0.0042	0.0042	CcSEcCtD
Cefoxitin—Urinary tract disorder—Sunitinib—pancreatic cancer	0.00415	0.00415	CcSEcCtD
Cefoxitin—Urethral disorder—Sunitinib—pancreatic cancer	0.00412	0.00412	CcSEcCtD
Cefoxitin—Eosinophilia—Fluorouracil—pancreatic cancer	0.0041	0.0041	CcSEcCtD
Cefoxitin—Neutropenia—Irinotecan—pancreatic cancer	0.00404	0.00404	CcSEcCtD
Cefoxitin—Phlebitis—Docetaxel—pancreatic cancer	0.00402	0.00402	CcSEcCtD
Cefoxitin—Pancytopenia—Gemcitabine—pancreatic cancer	0.004	0.004	CcSEcCtD
Cefoxitin—Thrombophlebitis—Docetaxel—pancreatic cancer	0.004	0.004	CcSEcCtD
Cefoxitin—Erythema multiforme—Sunitinib—pancreatic cancer	0.00397	0.00397	CcSEcCtD
Cefoxitin—Anaemia—Tamoxifen—pancreatic cancer	0.00395	0.00395	CcSEcCtD
Cefoxitin—Neutropenia—Gemcitabine—pancreatic cancer	0.00394	0.00394	CcSEcCtD
Cefoxitin—Pancytopenia—Fluorouracil—pancreatic cancer	0.00393	0.00393	CcSEcCtD
Cefoxitin—Angioedema—Tamoxifen—pancreatic cancer	0.0039	0.0039	CcSEcCtD
Cefoxitin—Flushing—Sunitinib—pancreatic cancer	0.0039	0.0039	CcSEcCtD
Cefoxitin—Leukopenia—Tamoxifen—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Cefoxitin—Jaundice—Irinotecan—pancreatic cancer	0.00376	0.00376	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00372	0.00372	CcSEcCtD
Cefoxitin—Erythema—Sunitinib—pancreatic cancer	0.00366	0.00366	CcSEcCtD
Cefoxitin—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Cefoxitin—Haemoglobin—Irinotecan—pancreatic cancer	0.00348	0.00348	CcSEcCtD
Cefoxitin—Haemorrhage—Irinotecan—pancreatic cancer	0.00346	0.00346	CcSEcCtD
Cefoxitin—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00345	0.00345	CcSEcCtD
Cefoxitin—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00341	0.00341	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Epirubicin—pancreatic cancer	0.0034	0.0034	CcSEcCtD
Cefoxitin—Haemoglobin—Gemcitabine—pancreatic cancer	0.00339	0.00339	CcSEcCtD
Cefoxitin—Anaemia—Sunitinib—pancreatic cancer	0.00338	0.00338	CcSEcCtD
Cefoxitin—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00338	0.00338	CcSEcCtD
Cefoxitin—Haemorrhage—Gemcitabine—pancreatic cancer	0.00337	0.00337	CcSEcCtD
Cefoxitin—Angioedema—Sunitinib—pancreatic cancer	0.00334	0.00334	CcSEcCtD
Cefoxitin—Haemoglobin—Fluorouracil—pancreatic cancer	0.00333	0.00333	CcSEcCtD
Cefoxitin—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.00333	0.00333	CcSEcCtD
Cefoxitin—Haemorrhage—Fluorouracil—pancreatic cancer	0.00332	0.00332	CcSEcCtD
Cefoxitin—Urethral disorder—Gemcitabine—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Cefoxitin—Leukopenia—Sunitinib—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Cefoxitin—Vaginal inflammation—Epirubicin—pancreatic cancer	0.00321	0.00321	CcSEcCtD
Cefoxitin—Flushing—Irinotecan—pancreatic cancer	0.00321	0.00321	CcSEcCtD
Cefoxitin—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Cefoxitin—Convulsion—Sunitinib—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Doxorubicin—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00312	0.00312	CcSEcCtD
Cefoxitin—Dyspnoea—Tamoxifen—pancreatic cancer	0.00311	0.00311	CcSEcCtD
Cefoxitin—Colitis—Epirubicin—pancreatic cancer	0.00309	0.00309	CcSEcCtD
Cefoxitin—Dyspnoea—Erlotinib—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Cefoxitin—Candida infection—Epirubicin—pancreatic cancer	0.00307	0.00307	CcSEcCtD
Cefoxitin—Vaginal infection—Epirubicin—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Cefoxitin—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Cefoxitin—Pain—Tamoxifen—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Cefoxitin—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.00297	0.00297	CcSEcCtD
Cefoxitin—Pain—Erlotinib—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Cefoxitin—Erythema—Gemcitabine—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Cefoxitin—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00292	0.00292	CcSEcCtD
Cefoxitin—Rash maculo-papular—Epirubicin—pancreatic cancer	0.00292	0.00292	CcSEcCtD
Cefoxitin—Erythema—Fluorouracil—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Cefoxitin—Colitis—Doxorubicin—pancreatic cancer	0.00286	0.00286	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Cefoxitin—Candida infection—Doxorubicin—pancreatic cancer	0.00284	0.00284	CcSEcCtD
Cefoxitin—Pancytopenia—Docetaxel—pancreatic cancer	0.00284	0.00284	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Cefoxitin—Vaginal infection—Doxorubicin—pancreatic cancer	0.00281	0.00281	CcSEcCtD
Cefoxitin—Neutropenia—Docetaxel—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Cefoxitin—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00279	0.00279	CcSEcCtD
Cefoxitin—Anaemia—Irinotecan—pancreatic cancer	0.00279	0.00279	CcSEcCtD
Cefoxitin—Urticaria—Tamoxifen—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Cefoxitin—Abdominal pain—Tamoxifen—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Cefoxitin—Abdominal pain—Erlotinib—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Cefoxitin—Body temperature increased—Erlotinib—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Cefoxitin—Anaemia—Gemcitabine—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Cefoxitin—Phlebitis—Epirubicin—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Cefoxitin—Rash maculo-papular—Doxorubicin—pancreatic cancer	0.0027	0.0027	CcSEcCtD
Cefoxitin—Leukopenia—Irinotecan—pancreatic cancer	0.0027	0.0027	CcSEcCtD
Cefoxitin—Thrombophlebitis—Epirubicin—pancreatic cancer	0.0027	0.0027	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Cefoxitin—Anaemia—Fluorouracil—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Cefoxitin—Dyspnoea—Sunitinib—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Cefoxitin—Leukopenia—Gemcitabine—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Cefoxitin—Jaundice—Docetaxel—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Cefoxitin—Leukopenia—Fluorouracil—pancreatic cancer	0.00258	0.00258	CcSEcCtD
Cefoxitin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Cefoxitin—Pain—Sunitinib—pancreatic cancer	0.00255	0.00255	CcSEcCtD
Cefoxitin—Renal failure acute—Epirubicin—pancreatic cancer	0.00253	0.00253	CcSEcCtD
Cefoxitin—Phlebitis—Doxorubicin—pancreatic cancer	0.00251	0.00251	CcSEcCtD
Cefoxitin—Convulsion—Fluorouracil—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Cefoxitin—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Cefoxitin—Agranulocytosis—Docetaxel—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Cefoxitin—Pruritus—Tamoxifen—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Cefoxitin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Cefoxitin—Pruritus—Erlotinib—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Cefoxitin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Cefoxitin—Haemoglobin—Docetaxel—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Cefoxitin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Cefoxitin—Haemorrhage—Docetaxel—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Cefoxitin—Diarrhoea—Tamoxifen—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Cefoxitin—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Cefoxitin—Body temperature increased—Sunitinib—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Cefoxitin—Abdominal pain—Sunitinib—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Cefoxitin—Diarrhoea—Erlotinib—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Cefoxitin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Cefoxitin—Urethral disorder—Docetaxel—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Cefoxitin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Cefoxitin—Renal failure acute—Doxorubicin—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Cefoxitin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Cefoxitin—Hypotension—Irinotecan—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Cefoxitin—Erythema multiforme—Docetaxel—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Cefoxitin—Hypotension—Gemcitabine—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Cefoxitin—Flushing—Docetaxel—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Cefoxitin—Vomiting—Tamoxifen—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Cefoxitin—Hypotension—Fluorouracil—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Cefoxitin—Hypersensitivity—Sunitinib—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Cefoxitin—Rash—Tamoxifen—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Cefoxitin—Dermatitis—Tamoxifen—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Cefoxitin—Vomiting—Erlotinib—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Cefoxitin—Dyspnoea—Irinotecan—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Cefoxitin—Rash—Erlotinib—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Cefoxitin—Dermatitis—Erlotinib—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Cefoxitin—Dyspnoea—Gemcitabine—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Cefoxitin—Pruritus—Sunitinib—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Cefoxitin—Pain—Irinotecan—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Dyspnoea—Fluorouracil—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Erythema—Docetaxel—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Cefoxitin—Nausea—Tamoxifen—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Cefoxitin—Pain—Gemcitabine—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Cefoxitin—Nausea—Erlotinib—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Cefoxitin—Diarrhoea—Sunitinib—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Cefoxitin—Pain—Fluorouracil—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Cefoxitin—Eosinophilia—Epirubicin—pancreatic cancer	0.002	0.002	CcSEcCtD
Cefoxitin—Abdominal pain—Irinotecan—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Cefoxitin—Body temperature increased—Irinotecan—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Cefoxitin—Anaemia—Docetaxel—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Cefoxitin—Pancytopenia—Epirubicin—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Cefoxitin—Vomiting—Sunitinib—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Cefoxitin—Body temperature increased—Gemcitabine—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Cefoxitin—Neutropenia—Epirubicin—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Cefoxitin—Rash—Sunitinib—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Cefoxitin—Dermatitis—Sunitinib—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Cefoxitin—Urticaria—Fluorouracil—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Cefoxitin—Leukopenia—Docetaxel—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Cefoxitin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Cefoxitin—Eosinophilia—Doxorubicin—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Cefoxitin—Hypersensitivity—Irinotecan—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Convulsion—Docetaxel—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Cefoxitin—Nausea—Sunitinib—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Pancytopenia—Doxorubicin—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Jaundice—Epirubicin—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Cefoxitin—Neutropenia—Doxorubicin—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Cefoxitin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Cefoxitin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Cefoxitin—Pruritus—Gemcitabine—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Cefoxitin—Diarrhoea—Irinotecan—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Cefoxitin—Agranulocytosis—Epirubicin—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Cefoxitin—Pruritus—Fluorouracil—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Cefoxitin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Cefoxitin—Diarrhoea—Gemcitabine—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Cefoxitin—Haemoglobin—Epirubicin—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Cefoxitin—Jaundice—Doxorubicin—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Cefoxitin—Haemorrhage—Epirubicin—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Cefoxitin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Cefoxitin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Cefoxitin—Hypotension—Docetaxel—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Cefoxitin—Urethral disorder—Epirubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Cefoxitin—Vomiting—Irinotecan—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Cefoxitin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Cefoxitin—Rash—Irinotecan—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Cefoxitin—Dermatitis—Irinotecan—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Cefoxitin—Erythema multiforme—Epirubicin—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Vomiting—Gemcitabine—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Cefoxitin—Dyspnoea—Docetaxel—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Cefoxitin—Rash—Gemcitabine—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Cefoxitin—Dermatitis—Gemcitabine—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Cefoxitin—Haemoglobin—Doxorubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Flushing—Epirubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Vomiting—Fluorouracil—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Haemorrhage—Doxorubicin—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Cefoxitin—Rash—Fluorouracil—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Cefoxitin—Dermatitis—Fluorouracil—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Cefoxitin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Cefoxitin—Urethral disorder—Doxorubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Cefoxitin—Nausea—Irinotecan—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Cefoxitin—Pain—Docetaxel—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Cefoxitin—Nausea—Gemcitabine—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Cefoxitin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Cefoxitin—Erythema—Epirubicin—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Cefoxitin—Nausea—Fluorouracil—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Cefoxitin—Flushing—Doxorubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Cefoxitin—Abdominal pain—Docetaxel—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Cefoxitin—Body temperature increased—Docetaxel—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Cefoxitin—Erythema—Doxorubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Cefoxitin—Anaemia—Epirubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Cefoxitin—Leukopenia—Epirubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Cefoxitin—Hypersensitivity—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Cefoxitin—Convulsion—Epirubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Cefoxitin—Pruritus—Docetaxel—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Cefoxitin—Anaemia—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Cefoxitin—Leukopenia—Doxorubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Cefoxitin—Diarrhoea—Docetaxel—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Cefoxitin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Cefoxitin—Convulsion—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Cefoxitin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefoxitin—Vomiting—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Cefoxitin—Rash—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefoxitin—Hypotension—Epirubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefoxitin—Dermatitis—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefoxitin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Cefoxitin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefoxitin—Dyspnoea—Epirubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Cefoxitin—Nausea—Docetaxel—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Cefoxitin—Hypotension—Doxorubicin—pancreatic cancer	0.000992	0.000992	CcSEcCtD
Cefoxitin—Pain—Epirubicin—pancreatic cancer	0.000981	0.000981	CcSEcCtD
Cefoxitin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000946	0.000946	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000938	0.000938	CcSEcCtD
Cefoxitin—Urticaria—Epirubicin—pancreatic cancer	0.000911	0.000911	CcSEcCtD
Cefoxitin—Pain—Doxorubicin—pancreatic cancer	0.000907	0.000907	CcSEcCtD
Cefoxitin—Body temperature increased—Epirubicin—pancreatic cancer	0.000907	0.000907	CcSEcCtD
Cefoxitin—Abdominal pain—Epirubicin—pancreatic cancer	0.000907	0.000907	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000868	0.000868	CcSEcCtD
Cefoxitin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000845	0.000845	CcSEcCtD
Cefoxitin—Urticaria—Doxorubicin—pancreatic cancer	0.000843	0.000843	CcSEcCtD
Cefoxitin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000839	0.000839	CcSEcCtD
Cefoxitin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000839	0.000839	CcSEcCtD
Cefoxitin—Pruritus—Epirubicin—pancreatic cancer	0.000811	0.000811	CcSEcCtD
Cefoxitin—Diarrhoea—Epirubicin—pancreatic cancer	0.000785	0.000785	CcSEcCtD
Cefoxitin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000782	0.000782	CcSEcCtD
Cefoxitin—Pruritus—Doxorubicin—pancreatic cancer	0.000751	0.000751	CcSEcCtD
Cefoxitin—Vomiting—Epirubicin—pancreatic cancer	0.000729	0.000729	CcSEcCtD
Cefoxitin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000726	0.000726	CcSEcCtD
Cefoxitin—Rash—Epirubicin—pancreatic cancer	0.000723	0.000723	CcSEcCtD
Cefoxitin—Dermatitis—Epirubicin—pancreatic cancer	0.000722	0.000722	CcSEcCtD
Cefoxitin—Nausea—Epirubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Cefoxitin—Vomiting—Doxorubicin—pancreatic cancer	0.000675	0.000675	CcSEcCtD
Cefoxitin—Rash—Doxorubicin—pancreatic cancer	0.000669	0.000669	CcSEcCtD
Cefoxitin—Dermatitis—Doxorubicin—pancreatic cancer	0.000668	0.000668	CcSEcCtD
Cefoxitin—Nausea—Doxorubicin—pancreatic cancer	0.00063	0.00063	CcSEcCtD
